Antiangiogenic Therapies: Going beyond Their Limits
Lidia Moserle(Institut d'Investigació Biomédica de Bellvitge), Oriol Casanovas(Institut Català d'Oncologia), Gabriela Jiménez-Valerio(Institut d'Investigació Biomédica de Bellvitge)
Cited by 101
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling
|Nature|2012|365
Unraveling the Role of Angiogenesis in Cancer Ecosystems
|Frontiers in Oncology|2018|275
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
|Proceedings of the National Academy of Sciences|2011|255